Angitia Biopharmaceuticals, Inc.
Overview
Angitia Biopharmaceuticals is a biotechnology company focused on the development of novel therapeutics targeting unmet medical needs in various therapeutic areas. The company is dedicated to advancing its pipeline of innovative drug candidates through clinical development.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Angitia Biopharmaceuticals, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Related companies
AstraZeneca Pharmaceuticals LP
USA
Bristol-Myers Squibb Company
USA
Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership
United States
Catalent, Inc.
United States
Eli Lilly and Company
United States
Global Biopharmaceuticals Inc.
USA
Globex Pharmaceuticals Inc.
USA
Health Innovations Incorporated
United States
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.